TY - JOUR
T1 - Blood and Marrow Transplant Clinical Trials Network State of the Science Symposium 2007
AU - Ferrara, James L M
AU - Anasetti, Claudio
AU - Stadtmauer, Edward
AU - Antin, Joseph
AU - Wingard, John
AU - Lee, Stephanie
AU - Levine, John
AU - Schultz, Kirk
AU - Appelbaum, Frederick
AU - Negrin, Robert
AU - Giralt, Sergio
AU - Bredeson, Christopher
AU - Heslop, Helen
AU - Horowitz, Mary
N1 - Funding Information:
The authors would like to acknowledge the financial support of the symposium from its sponsors: the American Cancer Society, The American Society for Blood and Marrow Transplantation, the Doris Duke Charitable Foundation, the Leukemia and Lymphoma Society, the National Marrow Donor Program, the National Heart, Lung and Blood Institute, the National Cancer Institute and the NIH Office of Rare Diseases. The authors would also like to acknowledge E. Holler, G. Socié, A. Bacigalupo, M. Labopin and J. H. F. Falkenburg for their expert reviews, critiques, and participation; S. Sonis, K. Cooke and J. Chien for their expert advice to Committee 2; D. Weisdorf and D. Confer for facilitation of audience questions; C. Farvar, D. Waldoch, P. Watry, P. Brown, L. Papp, C. Rowe, S. Chamberlain and F. Ferrara for superb logistical organization; and C. Kawala for expert manuscript preparation. Funding for this conference was also made possible in part by 1 R13 HL88882-01 from the National Institutes of Health. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Departments of Health and Human Services, nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
PY - 2007/11
Y1 - 2007/11
N2 - Outcomes of hematopoietic cell transplantation are steadily improving. New techniques have reduced transplant toxicities, and there are new sources of hematopoietic stem cells from unrelated donors. In June 2007 the Blood and Marrow Transplant Clinical Trials Network convened a State of the Science Symposium of more than 200 participants in Ann Arbor to identify the most compelling clinical research opportunities in the field. This report summarizes the symposium's discussions and identifies eleven high priority clinical trials that the network plans to pursue over the course of the next several years.
AB - Outcomes of hematopoietic cell transplantation are steadily improving. New techniques have reduced transplant toxicities, and there are new sources of hematopoietic stem cells from unrelated donors. In June 2007 the Blood and Marrow Transplant Clinical Trials Network convened a State of the Science Symposium of more than 200 participants in Ann Arbor to identify the most compelling clinical research opportunities in the field. This report summarizes the symposium's discussions and identifies eleven high priority clinical trials that the network plans to pursue over the course of the next several years.
KW - Acute lymphocytic leukemia
KW - Acute myeloid leukemia
KW - Biomarkers
KW - Cell therapy
KW - Chronic lymphocytic leukemia
KW - Clinical trials
KW - Clinical Trials Network
KW - Crohn's disease
KW - Graft versus host disease
KW - Hemaphogocytic lymphohistiocytosis
KW - Hematopoietic cell transplantation
KW - Quality of life
KW - T cell lymphoma
UR - http://www.scopus.com/inward/record.url?scp=35348912524&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=35348912524&partnerID=8YFLogxK
U2 - 10.1016/j.bbmt.2007.08.005
DO - 10.1016/j.bbmt.2007.08.005
M3 - Review article
C2 - 17950914
AN - SCOPUS:35348912524
SN - 1083-8791
VL - 13
SP - 1268
EP - 1285
JO - Biology of Blood and Marrow Transplantation
JF - Biology of Blood and Marrow Transplantation
IS - 11
ER -